Burning Rock Biotech (BNR) Stock: Buy, Sell, or Hold?
BNR - Burning Rock Biotech Limited American Depositary Shares
$11.10
-1.16 (-9.46%)
▼
5d:
-16.23%
30d:
-37.04%
90d:
+24.72%
HOLD
LOW Confidence
Analysis Updated: Oct 28, 2026 12:00 AM ET
Earnings: Nov 19, 2026
20d
Get Alerted When BNR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BNR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BNR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BNR is currently trading at $11.10, which is considered oversold relative to its 30-day fair value range of $12.65 to $17.01.
Technical Outlook: Technically, BNR is in a strong uptrend. The price is currently testing key support at $10.98. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.5% recently.
Market Sentiment: BNR scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $4.03. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BNR is in a strong uptrend. The price is currently testing key support at $10.98. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.5% recently.
Market Sentiment: BNR scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $4.03. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$12.65 -
$17.01
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.5%)
- BEARISH: Trading 67.1% above Wall St target ($4.03)
- CAUTION: Bottoming setup, but lagging the sector by 19% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-16.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$12.65 -
$17.01
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$10.98
Resistance Level
$16.36
Current Trend
Strong Uptrend
Technical data as of
Oct 28, 2026
Fundamental Context
Wall Street Target
$4.03
(-67.1%)
Revenue Growth (YoY)
-9.3%
Profit Margin
-13.6%
Share & Embed Analysis
Last updated: October 29, 2026 12:01 PM ET
Data refreshes hourly during market hours. Next update: 1:01 PM
Data refreshes hourly during market hours. Next update: 1:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$751 | 47 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 39 SELL |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$411 | 45 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$259 | 44 HOLD |
